JG
HPTX

Jefferies Group’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Jefferies Group’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-37,500
Closed -$979K – 2693
2014
Q2 		$979K Buy
+37,500
New +$964K 0.01% 912

Other funds holding HPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jefferies Group's HPTX Position: Q3 2014 in Review

Jefferies Group sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q3 2014, closing a stake of 37,500 shares — an estimated $979K sold.

Jefferies Group first reported a position in HPTX in Q2 2014 and held it in 1 quarter. The position peaked at $979K in Q2 2014. 97 funds tracked by Wall St. Rank hold HPTX as of Q3 2014.

  • Jefferies Group reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Jefferies Group sold 37,500 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $979K.
  • Jefferies Group first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Jefferies Group's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $979K in Q2 2014.
  • 97 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on Jefferies Group's 13F filing for Q3 2014, filed 17 Nov 2014.